Dried blood spots in doping analysis

Papers of special note have been highlighted as: • of interest

References

• 1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32, 338–343 (1963).
  Medline CASGoogle Scholar
• 2. Malsagova K, Kopylov A, Stepanov A, Butkova T, Izotov A, Kaysheva A. Dried blood spot in laboratory: directions and prospects. Diagnostics (Basel) 10(4), 248 (2020).
  Google Scholar
• 3. Tuaillon E, Kania D, Pisoni A et al. Dried blood spot tests for the diagnosis and therapeutic monitoring of HIV and viral hepatitis B and C. Front. Microbiol. 11, 373 (2020).
  MedlineGoogle Scholar
• 4. Travert G, Heeley M, Heeley A. History of newborn screening for cystic fibrosis-the early years. Int. J. Neonatal Screen. 6(1), 8 (2020).
  MedlineGoogle Scholar
• 5. Momosaki K, Kido J, Yoshida S et al. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients. J. Hum. Genet. 64(8), 741–755 (2019).
  Medline CASGoogle Scholar
• 6. Keutzer JM. Establishing Pompe disease newborn screening: the role of industry. Int. J. Neonatal Screen. 6(3), 55 (2020).
  MedlineGoogle Scholar
• 7. Sadones N, Capiau S, De Kesel PM, Lambert WE, Stove CP. Spot them in the spot: analysis of abused substances using dried blood spots. Bioanalysis 6(17), 2211–2227 (2014). • Discusses the advantages and limitations of the use of DBS in the doping field according to the classes listed in the WADA Prohibited List.
  CASGoogle Scholar
• 8. Moorthy GS, Vedar C, Downes KJ, Fitzgerald JC, Scheetz MH, Zuppa AF. Microsampling assays for pharmacokinetic analysis and therapeutic drug monitoring of antimicrobial drugs in children: a critical review. Ther. Drug Monit. 14, 5757–5771 (2020).
  Google Scholar
• 9. Tey HY, See HH. A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring. J. Chromatogr. A 1635, 461731 (2020).
  MedlineGoogle Scholar
• 10. Peng SH, Segura J, Farré M, de la Torre X. Oral testosterone administration detected by testosterone glucuronidation measured in blood spots dried on filter paper. Clin. Chem. 46(4), 515–522 (2000).
  Medline CASGoogle Scholar
• 11. Thevis M, Geyer H, Tretzel L, Schänzer W. Sports drug testing using complementary matrices: advantages and limitations. J. Pharm. Biomed. Anal. 130, 220–230 (2016). • Discusses the advantages and limitations of the use of DBS in the doping field according to the classes listed in the WADA Prohibited List.
  Medline CASGoogle Scholar
• 12. Thevis M, Kuuranne T, Dib J, Thomas A, Geyer H. Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? Drug Test. Anal. 12(6), 704–710 (2020).
  Medline CASGoogle Scholar
• 13. Lange T, Thomas A, Walpurgis K, Thevis M. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC–HRMS. Anal. Bioanal. Chem. 412(15), 3765–3777 (2020). • Provided the potential for using DBS with MS or HRMS to detect peptides and proteins, which is meaningful for the detection of the drug abuse of categories S2 and S4.
  Medline CASGoogle Scholar
• 14. Jones C, Dunseath GJ, Lemon J, Luzio SD. Microsampling collection methods for measurement of c-peptide in whole blood. J. Diabetes Sci. Technol. 12(5), 1024–1028 (2018).
  Medline CASGoogle Scholar
• 15. Luginbühl M, Angelova S, Gaugler S, Längin A, Weinmann W. Automated high-throughput analysis of tramadol and o-desmethyltramadol in dried blood spots. Drug Test. Anal. 12(8), 1126–1134 (2020).
  Medline CASGoogle Scholar
• 16. Verplaetse R, Henion J. Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE–LC–MS/MS. Drug Test. Anal. 8(1), 30–38 (2016).
  Medline CASGoogle Scholar
• 17. Thomas A, Thevis M, Yang S. Literature review of pharmacokinetic data in DBS samples for substances prohibited in-competition. World Anti-Doping Agency (2020). https://www.wada-ama.org/en/resources/science-medicine/literature-review-of-pharmacokinetic-data-in-dbs-samples-for-substances
  Google Scholar
• 18. Thomas A, Thevis M. Verification of the Conditions of Stability of Steroid Esters in DBS. World Anti-Doping Agency (2020). https://www.wada-ama.org/sites/default/files/resources/files/dbs20as5at_summary.pdf
  Google Scholar
• 19. World Anti-Doping Agency. World Anti-doping Code International Standard 2021 Prohibited List (2021). https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf
  Google Scholar
• 20. Solheim SA, Jessen S, Mørkeberg J et al. Single-dose administration of clenbuterol is detectable in dried blood spots. Drug Test. Anal. 12(9), 1366–1372 (2020).
  Medline CASGoogle Scholar
• 21. Cox HD, Rampton J, Eichner D. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport. Anal. Bioanal. Chem. 405(6), 1949–1958 (2013). • Provided the potential for using DBS with MS or HRMS to detect peptides and proteins, which is meaningful for the detection of the drug abuse of categories S2 and S4.
  Medline CASGoogle Scholar
• 22. Tretzel L, Görgens C, Geyer H et al. Analyses of meldonium (mildronate) from blood, dried blood spots (DBS), and urine suggest drug incorporation into erythrocytes. Int. J. Sports Med. 37(6), 500–502 (2016).
  Medline CASGoogle Scholar
• 23. Fedoruk M. Dried blood spot (DBS) testing & the potential for the ABP. Presented at: WADA ABP Symposium 2018. Rome, Italy (2018). https://www.wada-ama.org/sites/default/files/54_fedoruk_day_3_distribution.pdf
  Google Scholar
• 24. Blicharz TM, Gong P, Bunner BM et al. Microneedle-based device for the one-step painless collection of capillary blood samples. Nat. Biomed. Eng. 2(3), 151–157 (2018).
  Medline CASGoogle Scholar
• 25. Seventh Sense Biosystems. TAP^® .https://7sbio.com/products/tap/
  Google Scholar
• 26. Tasso. Tasso-M20 .https://www.tassoinc.com/tasso-m20
  Google Scholar
• 27. Neoteryx, LLC. Micro Sampling Capillary Blood Collection Devices .https://www.neoteryx.com/micro-sampling-capillary-blood-collection-devices
  Google Scholar
• 28. Spot On Sciences. Hemaspot HF .https://www.spotonsciences.com/hemaspot-hf
  Google Scholar
• 29. HemaXis. Hemaxis DB10 Whole Blood Collection Device. https://hemaxis.com/products/hemaxis-db10/
  Google Scholar
• 30. Salamin O, Garcia A, González-Ruiz V et al. Is pain temporary and glory forever? Detection of tramadol using dried blood spot in cycling competitions. Drug Test. Anal. 12(11–12), 1649–1657 (2020).
  Medline CASGoogle Scholar
• 31. Mørkeberg J, Solheim SA, Nordsborg NB, Dehnes Y. Athletes' Feedback and Impact of DBS Sampling Site (Fingertip Vsupper Arm) on the Concentrations of Endogenous Testosterone. World Anti-Doping Agency (2020) .https://www.wada-ama.org/sites/default/files/resources/files/dbs20ct34jm_summary.pdf
  Google Scholar
• 32. Tretzel L, Thomas A, Geyer H et al. Use of dried blood spots in doping control analysis of anabolic steroid esters. J. Pharm. Biomed. Anal. 96, 21–30 (2014). • Pointed out the derivatization of steroids could improve the sensitivity of the microsamples.
  Medline CASGoogle Scholar
• 33. Tretzel L, Thomas A, Geyer H, Pop Valentin, Schänzer W, Thevis M. Dried blood spots (DBS) in doping controls: a complementary matrix for improved in- and out- of-competition sports drug testing strategies. Anal. Methods 7(18), 7596–7605 (2015).
  CASGoogle Scholar
• 34. Thomas A, Thevis M. Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography–high resolution mass spectrometry. Drug Test. Anal. 10(11–12), 1761–1768 (2018).
  Medline CASGoogle Scholar
• 35. Thomas A, Geyer H, Guddat S, Schänzer W, Thevis M. Dried blood spots (DBS) for doping control analysis. Drug Test. Anal. 3(11–12), 806–813 (2011).
  CASGoogle Scholar
• 36. Möller I, Thomas A, Geyer H, Schänzer W, Thevis M. Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. Anal. Bioanal. Chem. 403(9), 2715–2724 (2012). • Provided the potential for using DBS with MS or HRMS to detect peptides and proteins, which is meaningful for the detection of the drug abuse of categories S2 and S4.
  MedlineGoogle Scholar
• 37. Rosting C, Sæ C, Gjelstad A, Halvorsen TG. Evaluation of water-soluble DBS for small proteins: a conceptual study using insulin as a model analyte. Bioanalysis 8(10), 1051–1065 (2016).
  CASGoogle Scholar
• 38. Thomas A, Geyer H, Schänzer W et al. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/orbitrap mass spectrometer. Anal. Bioanal. Chem. 403(5), 1279–1289 (2012).
  Medline CASGoogle Scholar
• 39. Singh GK, Turner L, Desai R, Jimenez M, Handelsman DJ. Pharmacokinetic–pharmacodynamic study of subcutaneous injection of depot nandrolone decanoate using dried blood spots sampling coupled with ultrapressure liquid chromatography tandem mass spectrometry assays. J. Clin. Endocrinol. Metab. 99(7), 2592–2598 (2014).
  Medline CASGoogle Scholar
• 40. Howe CJ, Handelsman DJ. Use of filter paper for sample collection and transport in steroid pharmacology. Clin. Chem. 43(8), 1408–1415 (1997).
  Medline CASGoogle Scholar
• 41. Tretzel L, Thomas A, Geyer H, Delahaut P, Schänzer W, Thevis M. Determination of Synacthen^® in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 407(16), 4709–4720 (2015). • Provided the potential for using DBS with MS or HRMS to detect peptides and proteins, which is meaningful for the detection of the drug abuse of categories S2 and S4.
  Medline CASGoogle Scholar
• 42. Abu-Rabie P, Denniff P, Spooner N, Brynjolffssen J, Galluzzo P, Sanders G. Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis. Anal. Chem. 83(22), 8779–8786 (2011).
  Medline CASGoogle Scholar
• 43. Abu-Rabie P, Denniff P, Spooner N, Chowdhry BZ, Pullen FS. Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias. Anal. Chem. 87(9), 4996–5003 (2015).
  Medline CASGoogle Scholar
• 44. Zimmer D, Hassler S, Betschart B, Sack S, Fankhauser C, Loppacher M. Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution. Bioanalysis 5(6), 711–719 (2013).
  CASGoogle Scholar
• 45. Mano Y, Kita K, Kusano K. Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra™. Bioanalysis 7(15), 1821–1829 (2015).
  CASGoogle Scholar
• 46. Parker SL, Roberts JA, Lipman J, Wallis SC. Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling. Bioanalysis 7(19), 2585–2595 (2015).
  CASGoogle Scholar
• 47. Forsdahl G, Erceg D, Geisendorfer T et al. Detection of testosterone esters in blood. Drug Test. Anal. 7(11–12), 983–989 (2015).
  Medline CASGoogle Scholar
• 48. Forsdahl G, Vatne HK, Geisendorfer T, Gmeiner G. Screening of testosterone esters in human plasma. Drug Test. Anal. 5(11–12), 826–833 (2013).
  Medline CASGoogle Scholar
• 49. Devi JL, Zahra P, Vine JH, Whittem T. Determination of testosterone esters in the hair of male greyhound dogs using liquid chromatography–high resolution mass spectrometry. Drug Test. Anal. 10(3), 460–473 (2018).
  Medline CASGoogle Scholar
• 50. Gray BP, Teale P, Pearce CM. Analysis of methyloxime derivatives of intact esters of testosterone and boldenone in equine plasma using ultra high performance liquid chromatography tandem mass spectrometry. Drug Test. Anal. 3(4), 206–213 (2011).
  Medline CASGoogle Scholar
• 51. Rocha DG, Lana MAG, de Assis DCS, Augusti R, Faria AF. Determination of steroids in bovine serum: validation of a reliable LC–MS/MS method and in vivo studies with boldenone undecylenate and testosterone propionate. J. Agric. Food Chem. 68(41), 11545–11552 (2020).
  Medline CASGoogle Scholar
• 52. Rocha DG, Lana MAG, de Assis DCS, Cançado SV, Augusti R, Faria AF. Determination of steroids in bovine hair: validation of a microwave-assisted chemical derivatization method using liquid chromatography–tandem mass spectrometry and in vivo studies. Drug Test. Anal. 12(8), 1078–1086 (2020).
  Medline CASGoogle Scholar
• 53. de la Torre X, Iannone M, Botrè F. Improving the detection of anabolic steroid esters in human serum by LC–MS. J. Pharm. Biomed. Anal. 5(194), 113807 (2021).
  Google Scholar
• 54. Shackleton CH, Chuang H, Kim J, de la Torre X, Segura J. Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62(7), 523–529 (1997).
  Medline CASGoogle Scholar
• 55. Athanasiadou I, Yiannis S, Angelis EL. Chemical derivatization to enhance ionization of anabolic steroids in LC–MS for doping-control analysis. Trends Anal. Chem. 42, 137–156 (2013).
  CASGoogle Scholar
• 56. Higashi T, Ogawa S. Chemical derivatization for enhancing sensitivity during LC/ESI–MS/MS quantification of steroids in biological samples: a review. J. Steroid Biochem. Mol. Biol. 162, 57–69 (2016).
  Medline CASGoogle Scholar
• 57. Marcos J, Pozo OJ. Derivatization of steroids in biological samples for GC–MS and LC–MS analyses. Bioanalysis 7(19), 2515–2536 (2015).
  CASGoogle Scholar
• 58. Star-Weinstock M, Williamson BL, Dey S, Pillai S, Purkayastha S. LC–ESI–MS/MS analysis of testosterone at sub-picogram levels using a novel derivatization reagent. Anal. Chem. 84(21), 9310–9317 (2012).
  Medline CASGoogle Scholar
• 59. Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M. Detection of peginesatide in equine serum using liquid chromatography–tandem mass spectrometry for doping control purposes. Eur. J. Mass Spectrom. 18(4), 407–412 (2012).
  MedlineGoogle Scholar
• 60. Lange T, Walpurgis K, Thomas A, Geyer H, Thevis M. Development of two complementary LC–HRMS methods for analyzing sotatercept in dried blood spots for doping controls. Bioanalysis 11(10), 923–940 (2019).
  CASGoogle Scholar
• 61. He G, Wu Y, Lu J. Doping control analysis of 13 steroids and structural-like analytes in human urine using quadrupole-orbitrap LC–MS/MS with parallel reaction monitoring (PRM) mode. Steroids 131, 1–6 (2018).
  MedlineGoogle Scholar
• 62. Tretzel L, Thomas A, Piper T et al. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online–SPE LC–HR–MS/MS approach for sports drug testing. J. Pharm. Biomed. Anal. 123, 132–140 (2016).
  Medline CASGoogle Scholar
• 63. Luginbühl M, Gaugler S. The application of fully automated dried blood spot analysis for liquid chromatography–tandem mass spectrometry using the CAMAG DBS-MS 500 autosampler. Clin. Biochem. 82, 33–39 (2020).
  MedlineGoogle Scholar
• 64. Velghe S, Delahaye L, Stove CP. Is the hematocrit still an issue in quantitative dried blood spot analysis? J. Pharm. Biomed. Anal. 163, 188–196 (2019).
  Medline CASGoogle Scholar
• 65. Kojima A, Nishitani Y, Sato M, Kageyama S, Dohi M, Okano M. Comparison of urine analysis and dried blood spot analysis for the detection of ephedrine and methylephedrine in doping control. Drug Test. Anal. 8(2), 189–198 (2016).
  Medline CASGoogle Scholar
• 66. Protti M, Catapano MC, Samolsky Dekel BG et al. Determination of oxycodone and its major metabolites in haematic and urinary matrices: comparison of traditional and miniaturised sampling approaches. J. Pharm. Biomed. Anal. 152, 204–214 (2018).
  Medline CASGoogle Scholar
• 67. Protti M, Rudge J, Sberna AE, Gerra G, Mercolini L. Dried haematic microsamples and LC–MS/MS for the analysis of natural and synthetic cannabinoids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1044–1045, 77–86 (2017).
  Medline CASGoogle Scholar
• 68. Cox HD, Miller GD, Lai A, Cushman D, Eichner D. Detection of autologous blood transfusions using a novel dried blood spot method. Drug Test. Anal. 9(11–12), 1713–1720 (2017).
  Medline CASGoogle Scholar
• 69. Höppner S, Delahaut P, Schänzer W, Thevis M. Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes. J. Pharm. Biomed. Anal. 88, 649–659 (2014).
  MedlineGoogle Scholar
• 70. Nair VS, Husk J, Miller GD, van Eenoo P, Crouch A, Eichner D. Evaluation of longitudinal steroid profiling with the Adams adaptive model for detection of transdermal, intramuscular, and subcutaneous testosterone administration. Drug Test. Anal. 12(10), 1419–1431 (2020).
  Medline CASGoogle Scholar
• 71. Forsdahl G, Zanitzer K, Erceg D, Gmeiner G. Quantification of endogenous steroid sulfates and glucuronides in human urine after intramuscular administration of testosterone esters. Steroids 157, 108614 (2020).
  Medline CASGoogle Scholar
• 72. Forsdahl G, Geisendorfer T, Göschl L et al. Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone. Drug Test. Anal. 10(8), 1244–1250 (2018).
  CASGoogle Scholar
• 73. Sobolevsky T, Rodchenkov G. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J. Steroid Biochem. Mol. Biol. 128(3–5), 121–127 (2012).
  Medline CASGoogle Scholar
• 74. Gray BP, Viljanto M, Bright J, Pearce C, Maynard S. Investigations into the feasibility of routine ultra high performance liquid chromatography–tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds. Anal. Chim. Acta 787, 163–172 (2013).
  Medline CASGoogle Scholar
• 75. Turner L, Ly LP, Desai R et al. Pharmacokinetics and acceptability of subcutaneous injection of testosterone undecanoate. J. Endocr. Soc. 3(8), 1531–1540 (2019).
  Medline CASGoogle Scholar
• 76. Guan F, Uboh CE, Soma LR, Luo Y, Rudy J, Tobin T. Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 829(1–2), 56–68 (2005).
  Medline CASGoogle Scholar
• 77. Jelkmann W. Watch out for a revival of peginesatide in sports. Drug Test. Anal. 9(2), 157–160 (2017).
  Medline CASGoogle Scholar
• 78. Möller I, Thomas A, Delahaut P, Geyer H, Schänzer W, Thevis M. Mass spectrometric detection of peginesatide in human urine in doping control analysis. J. Pharm. Biomed. Anal. 70, 512–517 (2012).
  MedlineGoogle Scholar
• 79. Thomas A, Görgens C, Guddat S et al. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. J. Sep. Sci. 39(2), 333–341 (2016).
  Medline CASGoogle Scholar
• 80. Reverter-Branchat G, Ventura R, Ezzel Din M et al. Detection of erythropoiesis-stimulating agents in a single dried blood spot. Drug Test. Anal. 10(10), 1496–1507 (2018).
  Medline CASGoogle Scholar
• 81. Powrie JK, Bassett EE, Rosen T et al. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 17(3), 220–226 (2007).
  Medline CASGoogle Scholar
• 82. Ferro P, Ventura R, Pérez-Mañá C, Farré M, Segura J. Evaluation of fibronectin 1 in one dried blood spot and in urine after rhGH treatment. Drug Test. Anal. 9(7), 1011–1016 (2017).
  Medline CASGoogle Scholar
• 83. Reverter-Branchat G, Bosch J, Vall J et al. Determination of recent growth hormone abuse using a single dried blood spot. Clin. Chem. 62(10), 1353–1360 (2016).
  Medline CASGoogle Scholar
• 84. Butter NL, Hattersley AT, Clark PM. Development of a bloodspot assay for insulin. Clin. Chim. Acta 310(2), 141–150 (2001).
  Medline CASGoogle Scholar
• 85. Kapur S, Kapur S, Zava D. Cardiometabolic risk factors assessed by a finger stick dried blood spot method. J. Diabetes Sci. Technol. 2(2), 236–241 (2008).
  MedlineGoogle Scholar
• 86. Kapur S, Groves MN, Zava DT, Kapur S. Postprandial insulin and triglycerides after different breakfast meal challenges: use of finger stick capillary dried blood spots to study postprandial dysmetabolism. J. Diabetes Sci. Technol. 4(2), 236–243 (2010).
  MedlineGoogle Scholar
• 87. Thomas A, Schänzer W, Thevis M. Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC–IM–MS). Drug Test. Anal. 6(11–12), 1125–1132 (2014).
  Medline CASGoogle Scholar
• 88. Johansson J, Becker C, Persson NG, Fex M, Törn C. C-peptide in dried blood spots. Scand. J. Clin. Lab. Invest. 70(6), 404–440 (2010).
  Medline CASGoogle Scholar
• 89. Willemsen RH, Burling K, Barker P et al. Frequent monitoring of C-peptide levels in newly diagnosed type 1 subjects using dried blood spots collected at home. J. Clin. Endocrinol. Metab. 103(9), 3350–3358 (2018).
  MedlineGoogle Scholar
• 90. Ryona I, Henion J. A book-type dried plasma spot card for automated flow-through elution coupled with online SPE–LC–MS/MS bioanalysis of opioids and stimulants in blood. Anal. Chem. 88(22), 11229–11237 (2016).
  Medline CASGoogle Scholar
• 91. Cox HD, Eichner D. Mass spectrometry method to measure membrane proteins in dried blood spots for the detection of blood doping practices in sport. Anal. Chem. 89(18), 10029–10036 (2017).
  Medline CASGoogle Scholar
• 92. Moat SJ, George RS, Carling RS. Use of dried blood spot specimens to monitor patients with inherited metabolic disorders. Int. J. Neonatal Screen. 6(2), 26 (2020).
  MedlineGoogle Scholar
• 93. De Kesel PM, Sadones N, Capiau S, Lambert WE, Stove CP. Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis 5(16), 2023–2041 (2013).
  Google Scholar
• 94. Luginbühl M, Gaugler S. Dried blood spots for anti-doping: why just going volumetric may not be sufficient. Drug Test. Anal. 13(1), 69–73 (2021).
  Medline CASGoogle Scholar
• 95. Luginbühl M, Fischer Y, Gaugler S. Fully automated optical hematocrit measurement from dried blood spots. J. Anal. Toxicol. DOI: 10.1093/jat/bkaa189 (.2020).
  MedlineGoogle Scholar
• 96. Capiau S, Wilk LS, Aalders MC, Stove CP. A novel, nondestructive, dried blood spot-based hematocrit prediction method using noncontact diffuse reflectance spectroscopy. Anal. Chem. 88(12), 6538–6546 (2016).
  Medline CASGoogle Scholar
• 97. de Oliveira FA, Casilli A, Piper T et al. Implementation and performance of the gas chromatography/combustion/isotope ratio mass spectrometry-based method for the confirmatory analysis of endogenous anabolic steroids during the Rio de Janeiro Olympic and Paralympic Games 2016. Anal. Chem. 91(18), 11747–11756 (2019).
  Medline CASGoogle Scholar
• 98. World Anti-Doping Agency. WADA Technical Document – TD2021IRMS (2020). https://www.wada-ama.org/sites/default/files/resources/files/td2021irms_final_eng.pdf
  Google Scholar
• 99. World Anti-Doping Agency. WADA Techinical Document – TD2021EPO (2020). https://www.wada-ama.org/sites/default/files/resources/files/td2021epo_final_eng.pdf
  Google Scholar
• 100. Fedoruk MN. Virtual drug testing: redefining sample collection in a global pandemic. Bioanalysis 12(11), 715–718 (2020).
  CASGoogle Scholar
• 101. Moeller BC, Yang Z. Evaluation of dried blood spots as an alternative sample matrix for equine antidoping analysis. Drug Test. Anal. 13(2), 386–396 (2021).
  Medline CASGoogle Scholar
• 102. Thevis M, Kuuranne T, Thomas A, Geyer H. Do dried blood spots have the potential to support result management processes in routine sports drug testing? Part 2: proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. Drug Test. Anal. doi:10.1002/dta.3011 (.2021) (Epub ahead of print).
  Google Scholar
• 103. Henion J, Oliveira RV, Chace DH. Microsample analyses via DBS: challenges and opportunities. Bioanalysis 5(20), 2547–2565 (2013).
  CASGoogle Scholar